The stock has a 36-month beta value of -5.28. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AMIX is 1.24M, and at present, short sellers hold a 22.87% of that float. On January 24, 2025, the average trading volume of AMIX was 881.44K shares.
AMIX) stock’s latest price update
Autonomix Medical Inc (NASDAQ: AMIX)’s stock price has gone decline by -6.85 in comparison to its previous close of 3.21, however, the company has experienced a -1.64% decrease in its stock price over the last five trading days. globenewswire.com reported 2025-01-17 that Design lock for ASIC microchip follows successful completion of in vivo preclinical and extensive bench testing Manufacturing of ASIC microchip for targeted use in humans has been initiated Company advancing toward submitting Investigational Device Exemption (“IDE”), and if approved, will commence a pivotal clinical trial to support a De Novo application for FDA approval THE WOODLANDS, TX, Jan. 17, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced it has finalized the design, achieving “design lock”, for its Application Specific Integrated Circuits (ASIC) microchip following the successful completion of in vivo preclinical testing and extensive bench testing, continuing progress toward its U.S. pivotal trial. “This design lock represents a significant milestone in the advancement of our innovative technology, placing us another step closer to commencing a pivotal clinical trial in the United States, planned in 2025.
AMIX’s Market Performance
Autonomix Medical Inc (AMIX) has seen a -1.64% fall in stock performance for the week, with a -0.33% decline in the past month and a -71.03% plunge in the past quarter. The volatility ratio for the week is 14.58%, and the volatility levels for the past 30 days are at 13.55% for AMIX. The simple moving average for the past 20 days is -5.88% for AMIX’s stock, with a -86.04% simple moving average for the past 200 days.
AMIX Trading at -42.85% from the 50-Day Moving Average
After a stumble in the market that brought AMIX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.03% of loss for the given period.
Volatility was left at 13.55%, however, over the last 30 days, the volatility rate increased by 14.58%, as shares sank -16.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -74.69% lower at present.
During the last 5 trading sessions, AMIX fell by -1.64%, which changed the moving average for the period of 200-days by -94.68% in comparison to the 20-day moving average, which settled at $3.18. In addition, Autonomix Medical Inc saw -20.48% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for AMIX
The total capital return value is set at -2.66.
Based on Autonomix Medical Inc (AMIX), the company’s capital structure generated 0.26 points at debt to capital in total, while cash flow to debt ratio is standing at -7.64. The debt to equity ratio resting at 0.36. The interest coverage ratio of the stock is -67.05.
Currently, EBITDA for the company is -15.27 million with net debt to EBITDA at 0.3. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.26.
Conclusion
To sum up, Autonomix Medical Inc (AMIX) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
